Tertiary lymphoid structures and B lymphocytes in cancer prognosis and response to immunotherapies-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Tertiary lymphoid structures and B lymphocytes in cancer prognosis and response to immunotherapies

Published:2021-01-01 Issue:1 Volume:10 Page:
ISSN:2162-402X
Container-title:OncoImmunology
language:en
Short-container-title:OncoImmunology

Author:

N Jacquelot¹²^ORCID,J Tellier¹²^ORCID,Sl Nutt¹²^ORCID,Gt Belz¹²³^ORCID

Affiliation:

1. Immunology Division, Walter and Eliza Hall Institute of Medical Research, Parkville, Australia

2. Department of Medical Biology, University of Melbourne, Parkville, Australia

3. The University of Queensland Diamantina Institute, the University of Queensland, Brisbane, Australia

Funder

Cure Cancer Australia Foundation

National Health and Medical Research Council

Publisher

Informa UK Limited

Subject

Oncology,Immunology,Immunology and Allergy

Link

https://www.tandfonline.com/doi/pdf/10.1080/2162402X.2021.1900508

Reference160 articles.

1. The immune contexture in cancer prognosis and treatment

2. Natural Innate and Adaptive Immunity to Cancer

3. B cells are associated with survival and immunotherapy response in sarcoma

4. B cells and tertiary lymphoid structures promote immunotherapy response

5. Tertiary lymphoid structures improve immunotherapy and survival in melanoma

Cited by 81 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Survival benefit and spatial properties of tertiary lymphoid structures in esophageal squamous cell carcinoma with neoadjuvant therapies;Cancer Letters;2024-10

2. Density of tertiary lymphoid structures and their correlation with prognosis in non-small cell lung cancer;Frontiers in Immunology;2024-08-13

3. Tertiary lymphoid structures and their therapeutic implications in cancer;Cellular Oncology;2024-08-12

4. Characteristics and clinical significance of tertiary lymphoid structures in OSCC;Oral Diseases;2024-07-24

5. Impact of tertiary lymphoid structures on prognosis and therapeutic response in pancreatic ductal adenocarcinoma;HPB;2024-07

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3